Astria Therapeutics, Inc.
ATXS$718M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBOSTON78 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Mar 2027
Market Overview
Stock performance and key metrics
ATXS News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
navenibart | Phase 3 | Hereditary Angioedema (HAE) | - | - |
STAR-0215 | Phase 2 | Hereditary Angioedema | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply